Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity. [electronic resource]
Producer: 20151006Description: 2811-21 p. digitalISSN:- 1538-7445
- Adenoviridae -- drug effects
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Antineoplastic Agents -- immunology
- Cells, Cultured
- Combined Modality Therapy
- Female
- Humans
- Inflammation -- prevention & control
- Integrin beta3 -- genetics
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Mice, Nude
- Oncolytic Virotherapy -- adverse effects
- Oncolytic Viruses -- drug effects
- Ovarian Neoplasms -- immunology
- Peptides, Cyclic -- pharmacology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.